4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Curis, Inc. (CRIS) operates in the Biotechnology industry and is headquartered in Lexington, United States with about 20 employees. Its market capitalization is roughly $9 million. In the fiscal year ended 2025-12-31, CRIS reported $9M in revenue and ($8M) in net income.
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States.
Interactive charts & full statements → Open the CRIS valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $9M | $11M | $10M | $10M | — |
| Gross Profit | $9M | $11M | $10M | $10M | — |
| Operating Income (EBIT) | ($33M) | ($44M) | ($48M) | ($53M) | — |
| Net Income | ($8M) | ($43M) | ($47M) | ($57M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $1M | $3M | $3M | $2M |
| Gross Profit | $0M | $1M | $3M | $3M | $2M |
| Operating Income (EBIT) | ($12M) | ($8M) | ($7M) | ($8M) | ($10M) |
| Net Income | ($24M) | $19M | ($8M) | ($9M) | ($11M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $20M | $41M | $77M | $109M | — |
| Total Liabilities | $14M | $47M | $58M | $62M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CRIS viewer.
About TickerBase · Data methodology & sources